,reactionmeddraversionpt,reactionmeddrapt,reactionoutcome,safetyreportid
0,22.1,Neuropathy peripheral,3,16982303
0,22.1,Interstitial lung disease,1,16982306
1,22.1,Anaemia,1,16982306
2,22.1,Malaise,1,16982306
0,22.1,Malignant neoplasm progression,6,16982310
1,22.1,Radiation pneumonitis,6,16982310
0,22.1,Stomatitis,6,16982319
1,22.1,Ovarian cancer,6,16982319
2,22.1,Blister,1,16982319
3,22.1,Malignant neoplasm progression,6,16982319
0,22.1,Ovarian cancer,6,16982320
1,22.1,Palmar-plantar erythrodysaesthesia syndrome,6,16982320
2,22.1,Malignant neoplasm progression,6,16982320
0,22.1,Acute kidney injury,2,16982325
1,22.1,Condition aggravated,2,16982325
0,22.1,Visual field defect,3,16982363
1,22.1,Necrotising retinitis,3,16982363
2,22.1,Retinal detachment,4,16982363
3,22.1,Visual impairment,3,16982363
4,22.1,Vision blurred,3,16982363
0,22.1,Neutrophil count decreased,2,16982406
1,22.1,Immunodeficiency,2,16982406
2,22.1,Urticaria,3,16982406
0,22.1,Anaemia,5,16982425
1,22.1,Therapy non-responder,5,16982425
2,22.1,Bile duct obstruction,5,16982425
3,22.1,Metastases to central nervous system,3,16982425
4,22.1,Malaise,5,16982425
5,22.1,Metastases to liver,3,16982425
0,22.1,Inappropriate schedule of product administration,6,16982429
1,22.1,Death,5,16982429
0,22.1,Malignant neoplasm progression,6,16982440
1,22.1,Lung disorder,6,16982440
2,22.1,Breast cancer female,6,16982440
3,22.1,Malaise,6,16982440
0,22.1,Hepatic cirrhosis,6,16982443
0,22.1,Pleural effusion,2,16982444
1,22.1,Ascites,2,16982444
2,22.1,Depressed mood,6,16982444
3,22.1,Respiratory distress,6,16982444
4,22.1,Drug intolerance,2,16982444
0,22.1,Renal impairment,2,16982464
1,22.1,Oedema,1,16982464
2,22.1,Cardiac failure,1,16982464
0,22.1,Liver disorder,6,16982473
1,22.1,Diarrhoea,6,16982473
2,22.1,Laboratory test abnormal,6,16982473
3,22.1,Cardiac disorder,6,16982473
4,22.1,Cardiac operation,6,16982473
5,22.1,Blood creatinine increased,6,16982473
6,22.1,Renal disorder,6,16982473
0,22.1,Suicide attempt,1,16982501
0,22.1,Colorectal cancer metastatic,6,16982503
1,22.1,Toxicity to various agents,6,16982503
2,22.1,Malignant neoplasm progression,6,16982503
3,22.1,Neuropathy peripheral,6,16982503
4,22.1,Neutropenia,6,16982503
0,22.1,Blood pressure fluctuation,2,16982583
1,22.1,Dizziness,1,16982583
2,22.1,Cough,6,16982583
3,22.1,Sneezing,6,16982583
4,22.1,Nasopharyngitis,1,16982583
0,22.1,Acute kidney injury,1,16982598
1,22.1,Colitis,1,16982598
0,22.1,Metastases to central nervous system,6,16982606
1,22.1,Malignant neoplasm progression,6,16982606
0,22.1,Respiratory tract infection,5,16982607
0,22.1,Tremor,6,16982608
1,22.1,Urinary tract infection,6,16982608
2,22.1,Dizziness,6,16982608
3,22.1,Decreased appetite,6,16982608
4,22.1,Off label use,6,16982608
5,22.1,Depression,6,16982608
6,22.1,Fatigue,6,16982608
7,22.1,Nausea,6,16982608
8,22.1,Acute kidney injury,6,16982608
9,22.1,Thrombocytopenia,6,16982608
10,22.1,Stomatitis,6,16982608
11,22.1,Anxiety,6,16982608
12,22.1,Anaemia,6,16982608
13,22.1,Syncope,6,16982608
14,22.1,Pneumonia,6,16982608
0,22.1,Ill-defined disorder,5,16982619
0,22.1,Oxygen saturation decreased,1,16982674
1,22.1,Pyrexia,1,16982674
2,22.1,Tremor,1,16982674
0,22.1,Disease progression,5,16982746
0,22.1,Proteinuria,6,16982755
0,22.1,Inappropriate schedule of product administration,6,16982759
1,22.1,Dizziness,6,16982759
2,22.1,Internal haemorrhage,6,16982759
3,22.1,Intestinal obstruction,6,16982759
4,22.1,Abdominal discomfort,3,16982759
0,22.1,Drug ineffective,6,16982844
1,22.1,Disease progression,1,16982844
0,22.1,Lung disorder,6,16982903
0,22.1,Malignant neoplasm progression,6,16982904
0,22.1,Dyspnoea,5,16982916
1,22.1,Pulmonary toxicity,5,16982916
0,22.1,Death,5,16982952
0,22.1,Nausea,1,16982990
1,22.1,Vomiting,1,16982990
0,22.1,Abdominal pain upper,3,16983070
1,22.1,Vomiting,3,16983070
0,22.1,Ill-defined disorder,3,16983073
1,22.1,Blood pressure systolic abnormal,3,16983073
2,22.1,Colon cancer,3,16983073
3,22.1,Somnolence,3,16983073
4,22.1,Blood pressure increased,3,16983073
5,22.1,Blood pressure systolic increased,3,16983073
0,22.1,Haemoglobin decreased,6,16983118
1,22.1,Fatigue,6,16983118
2,22.1,Nephritis,6,16983118
3,22.1,Blood creatinine increased,6,16983118
0,22.1,Death,5,16983194
0,22.1,Pyrexia,6,16983198
1,22.1,Malignant neoplasm progression,6,16983198
0,22.1,Arthritis,6,16983293
0,22.1,General physical health deterioration,6,16983295
1,22.1,Sciatic nerve injury,6,16983295
0,22.1,Diarrhoea,6,16983329
1,22.1,Headache,6,16983329
2,22.1,Dizziness,6,16983329
3,22.1,Muscle spasms,6,16983329
4,22.1,Fatigue,6,16983329
5,22.1,Gingival bleeding,6,16983329
6,22.1,Dehydration,6,16983329
7,22.1,Bone pain,6,16983329
8,22.1,Oral pain,6,16983329
9,22.1,Gingival abscess,6,16983329
10,22.1,Neuropathy peripheral,6,16983329
11,22.1,Hot flush,6,16983329
12,22.1,Dysphagia,6,16983329
13,22.1,Memory impairment,6,16983329
14,22.1,Nausea,6,16983329
0,22.1,Febrile neutropenia,5,16983360
1,22.1,Sepsis,5,16983360
0,22.1,Febrile neutropenia,5,16983363
1,22.1,Sepsis,5,16983363
0,22.1,Anaplastic thyroid cancer,1,16983368
1,22.1,Malignant neoplasm progression,1,16983368
0,22.1,Haematuria,6,16983370
1,22.1,Death,5,16983370
2,22.1,Pelvic pain,6,16983370
0,22.1,Fatigue,3,16983455
1,22.1,Pulmonary oedema,3,16983455
2,22.1,Dyspnoea,3,16983455
3,22.1,Gait inability,3,16983455
0,22.1,Mood altered,6,16983646
1,22.1,Full blood count decreased,6,16983646
2,22.1,Dementia,6,16983646
0,22.1,Blood count abnormal,6,16983671
0,22.1,Gastritis erosive,3,16983719
0,22.1,Asthenia,3,16983720
1,22.1,Adverse drug reaction,,16983720
0,22.1,Off label use,,16983722
1,22.1,Product supply issue,,16983722
2,22.1,Joint swelling,3,16983722
3,22.1,Product use in unapproved indication,,16983722
0,22.1,Gait disturbance,6,16983751
1,22.1,Fall,6,16983751
2,22.1,Femur fracture,6,16983751
0,22.1,Syncope,1,16983753
1,22.1,Sinus node dysfunction,1,16983753
2,22.1,Drug ineffective,6,16983753
3,22.1,Seizure,1,16983753
0,22.1,Suicidal ideation,1,16983782
1,22.1,Depression,1,16983782
0,22.1,Cutaneous lupus erythematosus,2,16983792
0,22.1,Asthenia,2,16983798
1,22.1,Diarrhoea,1,16983798
0,22.1,Intestinal obstruction,1,16983871
1,22.1,Product residue present,6,16983871
2,22.1,Product solubility abnormal,6,16983871
3,22.1,Incorrect dose administered,6,16983871
4,22.1,Diarrhoea,6,16983871
5,22.1,Dysphagia,6,16983871
0,22.1,Oesophageal perforation,6,16983876
0,22.1,Malignant neoplasm progression,6,16983880
0,22.1,Acute hepatic failure,5,16983885
1,22.1,Product use in unapproved indication,6,16983885
2,22.1,Encephalopathy,5,16983885
3,22.1,Off label use,6,16983885
0,22.1,Osteonecrosis of jaw,3,16983898
0,22.1,Diarrhoea,,16983908
1,22.1,Dysuria,3,16983908
0,22.1,Asthenia,2,16983918
0,22.1,Breast neoplasm,2,16983937
1,22.1,Acute kidney injury,1,16983937
2,22.1,Pyrexia,1,16983937
3,22.1,Tumour ulceration,2,16983937
4,22.1,Infected neoplasm,2,16983937
0,22.1,Thrombocytopenia,1,16983946
0,22.1,Death,5,16984018
0,22.1,Metastases to bone,6,16984036
1,22.1,Pleural effusion,6,16984036
2,22.1,Metastases to chest wall,6,16984036
3,22.1,Metastases to lymph nodes,6,16984036
0,22.1,Weight decreased,6,16984037
1,22.1,Pneumonia,5,16984037
2,22.1,Pulmonary fibrosis,5,16984037
0,22.1,Duodenal ulcer,6,16984072
0,22.1,Asthenia,6,16984089
1,22.1,Dyspnoea,6,16984089
2,22.1,Brain neoplasm,6,16984089
3,22.1,Malaise,6,16984089
4,22.1,Cardiac disorder,6,16984089
0,22.1,Paronychia,6,16984101
1,22.1,Neuropathy peripheral,6,16984101
2,22.1,Acne,6,16984101
0,22.1,Drug interaction,6,16984169
1,22.1,Cardiac arrest,1,16984169
2,22.1,Limb discomfort,6,16984169
3,22.1,Torsade de pointes,6,16984169
4,22.1,Electrocardiogram QT prolonged,2,16984169
5,22.1,Decreased appetite,6,16984169
6,22.1,Malaise,6,16984169
7,22.1,Ventricular fibrillation,2,16984169
0,22.1,Death,5,16984177
1,22.1,Off label use,6,16984177
2,22.1,Product use in unapproved indication,6,16984177
0,22.1,Neoplasm progression,6,16984543
0,22.1,Alopecia,6,16984556
1,22.1,Madarosis,6,16984556
0,22.1,Nausea,6,16984557
1,22.1,Increased tendency to bruise,6,16984557
0,22.1,Dizziness,6,16984558
1,22.1,Haemoglobin decreased,6,16984558
0,22.1,Constipation,6,16984577
0,22.1,Mouth ulceration,3,16984584
1,22.1,Fatigue,6,16984584
2,22.1,Stomatitis,2,16984584
3,22.1,Tongue ulceration,3,16984584
4,22.1,Lip ulceration,3,16984584
5,22.1,Rash pruritic,6,16984584
0,22.1,Death,5,16984626
0,22.1,Melaena,1,16984627
1,22.1,Mechanical ileus,1,16984627
0,22.1,Anxiety,6,16984633
1,22.1,Emotional distress,6,16984633
2,22.1,Pain,6,16984633
3,22.1,Impaired quality of life,6,16984633
4,22.1,Alopecia,2,16984633
0,22.1,Psychological trauma,6,16984644
1,22.1,Alopecia,2,16984644
0,22.1,Pain,6,16984653
1,22.1,Anxiety,6,16984653
2,22.1,Emotional distress,6,16984653
3,22.1,Alopecia,2,16984653
4,22.1,Psychological trauma,6,16984653
5,22.1,Impaired quality of life,6,16984653
0,22.1,Alopecia,2,16984661
1,22.1,Anxiety,6,16984661
2,22.1,Impaired quality of life,6,16984661
3,22.1,Pain,6,16984661
4,22.1,Emotional distress,6,16984661
0,22.1,Gait disturbance,6,16984677
1,22.1,Myalgia,6,16984677
2,22.1,Injection site swelling,6,16984677
3,22.1,Malignant neoplasm progression,6,16984677
0,22.1,Alopecia,2,16984693
1,22.1,Psychological trauma,6,16984693
0,22.1,Pneumonitis,6,16984695
0,22.1,Throat tightness,1,16984714
1,22.1,Dyspnoea,1,16984714
2,22.1,Laryngospasm,1,16984714
0,22.1,Nausea,6,16984724
1,22.1,Renal impairment,6,16984724
2,22.1,Fall,6,16984724
3,22.1,Myalgia,6,16984724
4,22.1,Arthralgia,6,16984724
0,22.1,Anxiety,6,16984731
1,22.1,Impaired quality of life,6,16984731
2,22.1,Alopecia,2,16984731
3,22.1,Pain,6,16984731
4,22.1,Emotional distress,6,16984731
5,22.1,Psychological trauma,6,16984731
0,22.1,Anxiety,6,16984752
1,22.1,Impaired quality of life,6,16984752
2,22.1,Emotional distress,6,16984752
3,22.1,Psychological trauma,6,16984752
4,22.1,Pain,6,16984752
5,22.1,Alopecia,2,16984752
0,22.1,Alopecia,2,16984759
0,22.1,Psychological trauma,6,16984765
1,22.1,Alopecia,2,16984765
0,22.1,Psychological trauma,6,16984767
1,22.1,Alopecia,2,16984767
0,22.1,Alopecia,3,16984794
1,22.1,Anxiety,6,16984794
2,22.1,Pain,6,16984794
3,22.1,Impaired quality of life,6,16984794
4,22.1,Psychological trauma,6,16984794
5,22.1,Emotional distress,6,16984794
0,22.1,Lethargy,,16984798
0,22.1,Malignant neoplasm progression,6,16984799
1,22.1,Rash,6,16984799
0,22.1,Hypoaesthesia,3,16984802
1,22.1,Nausea,3,16984802
0,22.1,Eastern Cooperative Oncology Group performance status worsened,3,16984805
1,22.1,Febrile neutropenia,6,16984805
2,22.1,Thrombocytopenia,6,16984805
0,22.1,Psychological trauma,6,16984820
1,22.1,Alopecia,2,16984820
0,22.1,Liver carcinoma ruptured,2,16984834
1,22.1,Gastrointestinal perforation,2,16984834
0,22.1,Alopecia,2,16984836
0,22.1,Respiratory failure,1,16984841
1,22.1,Hypotension,1,16984841
0,22.1,Alopecia,3,16984844
1,22.1,Impaired quality of life,6,16984844
2,22.1,Anxiety,6,16984844
3,22.1,Pain,6,16984844
4,22.1,Emotional distress,6,16984844
5,22.1,Psychological trauma,6,16984844
0,22.1,Immune thrombocytopenic purpura,1,16984867
0,22.1,Myocardial necrosis marker increased,,16984884
1,22.1,Fatigue,3,16984884
0,22.1,Osteonecrosis of jaw,1,16984893
0,22.1,Performance status decreased,,16984896
1,22.1,Cerebral infarction,1,16984896
0,22.1,Hospitalisation,,16984930
1,22.1,Abnormal dreams,3,16984930
0,22.1,Pain in extremity,6,16984935
1,22.1,Death,5,16984935
0,22.1,Pneumonitis,6,16984942
0,22.1,Pneumonitis,6,16984943
0,22.1,Hypokalaemia,2,16984947
1,22.1,Quadriplegia,2,16984947
0,22.1,Pneumonitis,6,16984965
0,22.1,Pneumonitis,6,16984966
0,22.1,Intestinal perforation,5,16984998
1,22.1,Hypotension,5,16984998
2,22.1,Ileus paralytic,5,16984998
3,22.1,Aplasia,5,16984998
0,22.1,Prostate cancer,,16985003
0,22.1,Fall,2,16985006
1,22.1,Dizziness,2,16985006
0,22.1,Fatigue,3,16985020
1,22.1,Taste disorder,3,16985020
2,22.1,Headache,3,16985020
3,22.1,Hypertension,3,16985020
4,22.1,Malaise,3,16985020
5,22.1,Dry skin,1,16985020
6,22.1,Arthritis,3,16985020
7,22.1,Pancreatitis,3,16985020
8,22.1,Frequent bowel movements,3,16985020
9,22.1,Fatigue,3,16985020
0,22.1,Left ventricular failure,6,16985021
1,22.1,Anaemia,6,16985021
0,22.1,Death,5,16985022
0,22.1,Osteonecrosis of jaw,1,16985036
0,22.1,Death,5,16985069
0,22.1,Prostate cancer,6,16985073
1,22.1,Terminal state,6,16985073
0,22.1,Infection,5,16985078
1,22.1,Product use in unapproved indication,1,16985078
2,22.1,Off label use,1,16985078
3,22.1,Leukopenia,5,16985078
0,22.1,Localised infection,2,16985082
1,22.1,Radiation injury,2,16985082
2,22.1,Radiation associated pain,2,16985082
0,22.1,Asthenia,3,16985091
1,22.1,Intestinal obstruction,3,16985091
2,22.1,Disease progression,3,16985091
3,22.1,Abdominal pain upper,3,16985091
4,22.1,Decreased appetite,3,16985091
0,22.1,Cardiac disorder,5,16985094
0,22.1,Rash,6,16985095
1,22.1,Fatigue,6,16985095
2,22.1,Neoplasm progression,6,16985095
3,22.1,Palpitations,6,16985095
4,22.1,Pericardial effusion,6,16985095
0,22.1,Anaemia,6,16985128
1,22.1,Gastrointestinal haemorrhage,6,16985128
2,22.1,Non-small cell lung cancer,5,16985128
3,22.1,Gamma-glutamyltransferase increased,6,16985128
0,22.1,Death,5,16985172
0,22.1,Aspartate aminotransferase increased,3,16985174
1,22.1,Alanine aminotransferase increased,3,16985174
2,22.1,Cholelithiasis,6,16985174
0,22.1,Bone pain,,16985208
1,22.1,Metastasis,5,16985208
0,22.1,Radiation pneumonitis,3,16985212
1,22.1,Metastases to bone,6,16985212
0,22.1,Hepatic function abnormal,2,16985215
1,22.1,Hepatic cyst,6,16985215
0,22.1,Basal cell carcinoma,1,16985239
0,22.1,Pulmonary embolism,1,16985243
0,22.1,Colon cancer,5,16985247
1,22.1,Neuropathy peripheral,6,16985247
2,22.1,Hypersensitivity,6,16985247
3,22.1,Weight decreased,6,16985247
4,22.1,Malignant neoplasm progression,5,16985247
0,22.1,Localised oedema,3,16985250
1,22.1,Delayed effects of radiation,3,16985250
0,22.1,Neuropathy peripheral,6,16985257
0,22.1,Pneumonia,6,16985274
1,22.1,Stomatitis,6,16985274
2,22.1,Transaminases increased,6,16985274
3,22.1,Neoplasm progression,2,16985274
0,22.1,Radiation pneumonitis,5,16985372
0,22.1,Multiple organ dysfunction syndrome,5,16985373
1,22.1,Asthenia,3,16985373
0,22.1,Retroperitoneal lymphadenopathy,6,16985405
1,22.1,Malignant neoplasm progression,6,16985405
2,22.1,Metastases to liver,6,16985405
3,22.1,Product use in unapproved indication,6,16985405
4,22.1,Non-small cell lung cancer,6,16985405
5,22.1,Central nervous system lesion,6,16985405
0,22.1,Arteriospasm coronary,6,16985433
0,22.1,Type 2 diabetes mellitus,1,16985443
0,22.1,Renal impairment,6,16985534
0,22.1,Neuropathy peripheral,3,16985539
1,22.1,Muscular weakness,3,16985539
2,22.1,Hypoaesthesia,3,16985539
3,22.1,Rheumatoid arthritis,6,16985539
4,22.1,Gait inability,3,16985539
0,22.1,Pancytopenia,3,16985541
1,22.1,Myelodysplastic syndrome,3,16985541
0,22.1,Intestinal obstruction,6,16985571
0,22.1,Emotional distress,6,16985606
1,22.1,Alopecia,2,16985606
2,22.1,Pain,6,16985606
3,22.1,Psychological trauma,6,16985606
4,22.1,Anxiety,6,16985606
5,22.1,Impaired quality of life,6,16985606
0,22.1,Colon cancer,5,16985614
1,22.1,Product use in unapproved indication,6,16985614
2,22.1,Disease progression,6,16985614
0,22.1,Psychological trauma,6,16985626
1,22.1,Alopecia,2,16985626
2,22.1,Anxiety,6,16985626
3,22.1,Pain,6,16985626
4,22.1,Emotional distress,6,16985626
5,22.1,Impaired quality of life,6,16985626
0,22.1,Pain,6,16985632
1,22.1,Impaired quality of life,6,16985632
2,22.1,Emotional distress,6,16985632
3,22.1,Anxiety,6,16985632
4,22.1,Psychological trauma,6,16985632
5,22.1,Alopecia,2,16985632
0,22.1,Product use in unapproved indication,6,16985640
1,22.1,Death,5,16985640
0,22.1,Tympanic membrane perforation,2,16985657
1,22.1,Product dose omission,3,16985657
2,22.1,Hypoacusis,3,16985657
3,22.1,Ear pain,3,16985657
4,22.1,Ear infection,2,16985657
0,22.1,Respiratory tract infection,1,16985694
1,22.1,Hyponatraemia,1,16985694
0,22.1,Disease progression,6,16985704
1,22.1,Neurotoxicity,6,16985704
0,22.1,Exfoliative rash,3,16985755
1,22.1,Pelvic pain,3,16985755
0,22.1,Feeling abnormal,6,16985771
1,22.1,Eating disorder,6,16985771
2,22.1,Dysgeusia,6,16985771
3,22.1,Dry skin,6,16985771
4,22.1,Drug intolerance,6,16985771
5,22.1,Oral mucosal exfoliation,6,16985771
6,22.1,Limb discomfort,6,16985771
7,22.1,Weight decreased,6,16985771
8,22.1,Metastasis,6,16985771
9,22.1,Metastases to spine,6,16985771
10,22.1,Mass,6,16985771
11,22.1,Skin exfoliation,6,16985771
12,22.1,Furuncle,6,16985771
0,22.1,Dementia,6,16985776
1,22.1,Underdose,6,16985776
0,22.1,Lupus-like syndrome,6,16985780
1,22.1,Laboratory test abnormal,6,16985780
2,22.1,Hypersensitivity,6,16985780
0,22.1,Hepatic lesion,6,16985781
1,22.1,Bone lesion,6,16985781
2,22.1,Neutropenia,3,16985781
3,22.1,Breast cancer,3,16985781
4,22.1,Cytopenia,6,16985781
5,22.1,Diarrhoea,6,16985781
6,22.1,Malignant neoplasm progression,3,16985781
0,22.1,Tremor,6,16985813
1,22.1,Dysphemia,6,16985813
2,22.1,Memory impairment,6,16985813
3,22.1,Confusional state,6,16985813
0,22.1,Myelodysplastic syndrome,6,16985827
1,22.1,Flank pain,6,16985827
2,22.1,Pancytopenia,6,16985827
3,22.1,Musculoskeletal chest pain,6,16985827
4,22.1,Nervous system disorder,6,16985827
0,22.1,Lip swelling,3,16985854
1,22.1,Gingival pain,3,16985854
2,22.1,Mouth swelling,3,16985854
3,22.1,Oral disorder,3,16985854
0,22.1,Neutropenia,3,16986128
0,22.1,Metastases to lung,6,16986139
1,22.1,Malaise,3,16986139
2,22.1,Rash,2,16986139
0,22.1,Vulvovaginal dryness,1,16986142
0,22.1,Toxic encephalopathy,5,16986147
0,22.1,Renal impairment,2,16986169
0,22.1,Posterior reversible encephalopathy syndrome,1,16986180
0,22.1,Hepatotoxicity,6,16986257
0,22.1,Infection,1,16986267
0,22.1,Off label use,1,16986312
1,22.1,Skin infection,1,16986312
2,22.1,Dry skin,1,16986312
3,22.1,Staphylococcal infection,1,16986312
4,22.1,Device related infection,1,16986312
5,22.1,Sepsis,1,16986312
0,22.1,Phlebitis,6,16986315
0,22.1,Death,5,16986349
0,22.1,Wrong technique in product usage process,6,16986361
1,22.1,Device use error,6,16986361
2,22.1,Anxiety,6,16986361
0,22.1,Pathological fracture,1,16986368
1,22.1,Death,5,16986368
2,22.1,Bone pain,2,16986368
0,22.1,Anaemia,2,16986374
1,22.1,Malignant neoplasm progression,5,16986374
2,22.1,Defaecation disorder,2,16986374
3,22.1,Stomatitis,1,16986374
4,22.1,Muscle spasms,1,16986374
5,22.1,Pruritus,3,16986374
6,22.1,Vision blurred,1,16986374
7,22.1,Oedema,3,16986374
0,22.1,Electrocardiogram QT prolonged,2,16986440
0,22.1,Deafness,6,16986580
0,22.1,Product use in unapproved indication,3,16986584
1,22.1,Death,5,16986584
2,22.1,Product dose omission,1,16986584
0,22.1,Taste disorder,6,16986658
1,22.1,Death,5,16986658
2,22.1,Fatigue,6,16986658
0,22.1,Malignant neoplasm progression,5,16986659
0,22.1,Death,5,16986661
0,22.1,Palliative care,6,16986792
0,22.1,Pericarditis,1,16986825
1,22.1,Constipation,6,16986825
2,22.1,Neoplasm progression,5,16986825
3,22.1,Subileus,1,16986825
4,22.1,Pain,1,16986825
0,22.1,Herpes zoster oticus,6,16986848
1,22.1,Facial paralysis,6,16986848
0,22.1,Pneumonia aspiration,1,16986852
1,22.1,Urinary retention,1,16986852
2,22.1,Subileus,1,16986852
0,22.1,Dizziness,2,16986876
1,22.1,Nausea,1,16986876
2,22.1,Vomiting,1,16986876
3,22.1,Hyponatraemia,1,16986876
0,22.1,Thrombocytopenia,6,16986910
1,22.1,Hypertransaminasaemia,6,16986910
0,22.1,Radiation associated pain,1,16986921
1,22.1,General physical health deterioration,3,16986921
2,22.1,Movement disorder,3,16986921
3,22.1,Neutropenia,1,16986921
4,22.1,White blood cell count decreased,6,16986921
5,22.1,Pain,3,16986921
0,22.1,Performance status decreased,6,16986941
1,22.1,Thrombocytopenia,6,16986941
2,22.1,Death,5,16986941
0,22.1,Death,5,16986945
0,22.1,Peripheral ischaemia,2,16986952
0,22.1,Bone cancer,3,16986984
1,22.1,Prostatic specific antigen increased,6,16986984
0,22.1,Feeling hot,1,16987138
1,22.1,Rash,1,16987138
0,22.1,Respiratory distress,1,16987139
0,22.1,Sepsis,6,16987173
1,22.1,Colitis,5,16987173
0,22.1,Acute kidney injury,2,16987264
1,22.1,Condition aggravated,2,16987264
0,22.1,Thrombocytopenia,2,16987271
1,22.1,Neutropenia,2,16987271
2,22.1,Alopecia,2,16987271
3,22.1,Leukopenia,2,16987271
0,22.1,Renal impairment,6,16987280
1,22.1,Drug ineffective,6,16987280
2,22.1,Metastases to liver,6,16987280
3,22.1,Malignant neoplasm progression,6,16987280
4,22.1,Pericardial effusion,6,16987280
5,22.1,Off label use,6,16987280
6,22.1,Breast cancer metastatic,6,16987280
0,22.1,Atrial fibrillation,6,16987290
1,22.1,Bundle branch block left,6,16987290
0,22.1,Pneumonitis,3,16987328
0,22.1,Dysphagia,1,16987329
1,22.1,Odynophagia,1,16987329
2,22.1,Abscess oral,1,16987329
0,22.1,Anticoagulation drug level above therapeutic,1,16987355
1,22.1,Drug interaction,6,16987355
2,22.1,Haematoma,6,16987355
0,22.1,Acute kidney injury,6,16987390
0,22.1,Back pain,6,16987391
1,22.1,Shock,6,16987391
2,22.1,Adrenocortical insufficiency acute,6,16987391
3,22.1,Pruritus,6,16987391
4,22.1,Musculoskeletal pain,6,16987391
5,22.1,Arthralgia,6,16987391
0,22.1,Electrocardiogram QT prolonged,6,16987401
1,22.1,Neutrophil count abnormal,6,16987401
2,22.1,Haemoglobin decreased,6,16987401
3,22.1,Bundle branch block right,6,16987401
4,22.1,Sinus rhythm,6,16987401
0,22.1,Nail disorder,3,16987438
1,22.1,Onychoclasis,3,16987438
2,22.1,Off label use,6,16987438
0,22.1,Hepatic lesion,6,16987471
1,22.1,Death,5,16987471
0,22.1,Malignant neoplasm progression,1,16987473
1,22.1,Drug intolerance,6,16987473
2,22.1,Malignant neoplasm progression,5,16987473
0,22.1,Death,5,16987487
1,22.1,Malignant neoplasm progression,6,16987487
0,22.1,Proteinuria,2,16987493
0,22.1,Post thrombotic syndrome,4,16987507
1,22.1,Deep vein thrombosis,4,16987507
0,22.1,Cellulitis,1,16987517
0,22.1,Multiple organ dysfunction syndrome,5,16987560
1,22.1,Malignant neoplasm progression,5,16987560
2,22.1,Pneumonia,5,16987560
3,22.1,Urinary tract infection,6,16987560
0,22.1,Death,5,16987602
0,22.1,Metastases to bone,6,16987689
0,22.1,Neutropenia,5,16987731
1,22.1,Diarrhoea,5,16987731
0,22.1,Peripheral sensory neuropathy,3,16987735
1,22.1,Neuropathy peripheral,3,16987735
0,22.1,Bacterial infection,1,16987737
1,22.1,Blood sodium decreased,1,16987737
2,22.1,Haemoglobin decreased,6,16987737
3,22.1,Pneumonia,6,16987737
4,22.1,White blood cell count decreased,1,16987737
5,22.1,Neutropenia,1,16987737
6,22.1,Blood lactate dehydrogenase increased,1,16987737
7,22.1,Gamma-glutamyltransferase increased,1,16987737
0,22.1,Optic neuritis,6,16987796
1,22.1,Hypopituitarism,6,16987796
0,22.1,Dry mouth,3,16987804
1,22.1,Drug ineffective,1,16987804
2,22.1,Dry eye,3,16987804
0,22.1,Disease progression,5,16987968
0,22.1,Disease progression,5,16987969
0,22.1,Disease progression,5,16987974
0,22.1,Liver function test increased,3,16988038
1,22.1,Electrocardiogram QT prolonged,3,16988038
2,22.1,Gamma-glutamyltransferase increased,6,16988038
0,22.1,Alanine aminotransferase increased,6,16988084
1,22.1,Aspartate aminotransferase increased,6,16988084
2,22.1,Haematochezia,6,16988084
3,22.1,Anaemia,6,16988084
0,22.1,Constipation,3,16988086
1,22.1,Colitis,5,16988086
0,22.1,Adverse event,3,16988112
1,22.1,Death,5,16988112
0,22.1,Nausea,6,16988121
1,22.1,Vomiting,6,16988121
2,22.1,Blood sodium decreased,1,16988121
3,22.1,Blood creatinine increased,1,16988121
4,22.1,Blood urea increased,1,16988121
5,22.1,Dehydration,1,16988121
0,22.1,Small intestinal obstruction,1,16988129
0,22.1,Cystitis,1,16988143
1,22.1,Neutrophil count decreased,1,16988143
2,22.1,Diarrhoea,1,16988143
3,22.1,Musculoskeletal pain,3,16988143
4,22.1,Fatigue,2,16988143
5,22.1,Urinary tract infection,1,16988143
6,22.1,Urinary retention,2,16988143
0,22.1,Chondrocalcinosis,2,16988261
0,22.1,Cataract operation,6,16988298
1,22.1,Fatigue,6,16988298
2,22.1,Underdose,6,16988298
3,22.1,Product dose omission,6,16988298
4,22.1,Nausea,1,16988298
0,22.1,Colitis,6,16988381
1,22.1,Large intestine perforation,5,16988381
0,22.1,Chills,1,16988390
1,22.1,Infusion related reaction,1,16988390
2,22.1,Dyspnoea,1,16988390
3,22.1,Livedo reticularis,1,16988390
0,22.1,Intentional product use issue,6,16988396
1,22.1,Death,5,16988396
2,22.1,Off label use,6,16988396
0,22.1,Delirium,2,16988435
1,22.1,Myofascial pain syndrome,6,16988435
2,22.1,Extrapyramidal disorder,6,16988435
3,22.1,Nausea,1,16988435
4,22.1,Lung adenocarcinoma,5,16988435
5,22.1,Dizziness,2,16988435
0,22.1,Suprapubic pain,3,16988449
1,22.1,Back pain,3,16988449
2,22.1,Discomfort,3,16988449
0,22.1,Non-small cell lung cancer,5,16988528
0,22.1,White blood cell count decreased,6,16988547
1,22.1,Odynophagia,6,16988547
2,22.1,Bone marrow toxicity,6,16988547
3,22.1,Febrile neutropenia,6,16988547
4,22.1,Diarrhoea,6,16988547
5,22.1,Fatigue,6,16988547
6,22.1,Mucosal inflammation,6,16988547
7,22.1,Drug intolerance,6,16988547
8,22.1,Herpes simplex pharyngitis,6,16988547
9,22.1,Anaemia,6,16988547
0,22.1,Hypertransaminasaemia,6,16988642
1,22.1,Thrombocytopenia,6,16988642
0,22.1,Non-small cell lung cancer,6,16988674
1,22.1,Malaise,6,16988674
0,22.1,Cholestasis,1,16988704
1,22.1,Liver disorder,6,16988704
2,22.1,Pneumonia,1,16988704
3,22.1,Myocarditis,3,16988704
0,22.1,Death,5,16988715
1,22.1,Intentional product use issue,6,16988715
0,22.1,Urine odour abnormal,6,16988805
1,22.1,Metastases to central nervous system,6,16988805
0,22.1,Pain in extremity,,16988830
0,22.1,Dyspnoea,,16988890
1,22.1,Pruritus,,16988890
0,22.1,Drug ineffective for unapproved indication,6,16988897
1,22.1,Death,5,16988897
2,22.1,Fall,6,16988897
3,22.1,Product use issue,6,16988897
4,22.1,Femur fracture,6,16988897
5,22.1,Pathological fracture,6,16988897
0,22.1,Death,5,16988899
0,22.1,Cytopenia,6,16988901
1,22.1,Intestinal ischaemia,6,16988901
2,22.1,Metastases to liver,6,16988901
3,22.1,Metastases to bone,6,16988901
4,22.1,Malignant neoplasm progression,6,16988901
0,22.1,Hepatic mass,6,16988983
1,22.1,Venoocclusive liver disease,6,16988983
2,22.1,Fibrosis,6,16988983
3,22.1,Stenosis,6,16988983
4,22.1,Hepatic atrophy,6,16988983
0,22.1,Death,5,16989081
0,22.1,Death,5,16989082
0,22.1,Death,5,16989084
0,22.1,Death,5,16989125
0,22.1,Alopecia,3,16989147
1,22.1,Hair texture abnormal,3,16989147
2,22.1,Madarosis,3,16989147
3,22.1,Hair disorder,3,16989147
4,22.1,Hair colour changes,3,16989147
0,22.1,Insomnia,6,16989174
0,22.1,Liver function test increased,6,16989177
0,22.1,Red blood cell count increased,6,16989187
1,22.1,Dyspepsia,6,16989187
2,22.1,Alopecia,6,16989187
3,22.1,Pain,2,16989187
4,22.1,Constipation,6,16989187
5,22.1,Hyperhidrosis,6,16989187
0,22.1,Muscle spasms,6,16989191
1,22.1,White blood cell count decreased,6,16989191
0,22.1,White blood cell count decreased,6,16989192
0,22.1,Fatigue,3,16989208
0,22.1,Death,5,16989212
0,22.1,Diarrhoea,,16989259
0,22.1,Product use complaint,,16989265
1,22.1,Eating disorder,,16989265
0,22.1,Vomiting,6,16989275
1,22.1,Dehydration,6,16989275
2,22.1,Diarrhoea,6,16989275
0,22.1,Death,,16989282
0,22.1,Neutropenia,6,16989284
0,22.1,Death,5,16989288
1,22.1,Anaemia,6,16989288
0,22.1,Hyperglycaemia,,16989291
0,22.1,Alopecia,3,16989318
1,22.1,Hair colour changes,3,16989318
2,22.1,Madarosis,3,16989318
3,22.1,Hair texture abnormal,3,16989318
4,22.1,Hair disorder,3,16989318
0,22.1,Malignant melanoma,6,16989368
0,22.1,Blood count abnormal,,16989401
1,22.1,Unevaluable event,,16989401
0,22.1,Death,5,16989416
0,22.1,Neoplasm progression,6,16989418
1,22.1,Pericardial effusion,6,16989418
0,22.1,Blood count abnormal,2,16989451
1,22.1,Product dose omission,6,16989451
0,22.1,Death,5,16989452
0,22.1,Alopecia,3,16989457
1,22.1,Hair disorder,3,16989457
2,22.1,Hair texture abnormal,3,16989457
3,22.1,Hair colour changes,3,16989457
4,22.1,Madarosis,3,16989457
0,22.1,Palmar-plantar erythrodysaesthesia syndrome,,16989463
0,22.1,Death,,16989476
0,22.1,Vomiting,6,16989490
1,22.1,Nausea,6,16989490
0,22.1,Alopecia,3,16989491
1,22.1,Hair disorder,3,16989491
2,22.1,Hair colour changes,3,16989491
3,22.1,Madarosis,3,16989491
4,22.1,Hair texture abnormal,3,16989491
0,22.1,Tissue infiltration,3,16989510
0,22.1,Asthenia,,16989516
1,22.1,White blood cell count decreased,,16989516
0,22.1,Neutropenia,6,16989531
1,22.1,Nausea,6,16989531
2,22.1,Anxiety,6,16989531
3,22.1,Asthenia,6,16989531
0,22.1,Lymphoedema,,16989575
0,22.1,Injection site erythema,,16989576
1,22.1,Lymphoedema,1,16989576
2,22.1,Product use in unapproved indication,,16989576
3,22.1,Off label use,,16989576
0,22.1,Headache,1,16989632
1,22.1,Vertigo,3,16989632
2,22.1,Angina pectoris,1,16989632
3,22.1,Polyneuropathy,1,16989632
4,22.1,Polyneuropathy,3,16989632
5,22.1,Off label use,6,16989632
6,22.1,Vertigo,1,16989632
7,22.1,Dyspnoea exertional,3,16989632
8,22.1,Blindness,4,16989632
0,22.1,Neoplasm progression,5,16989637
0,22.1,Acute kidney injury,6,16989698
1,22.1,Diarrhoea,6,16989698
2,22.1,Decreased appetite,6,16989698
3,22.1,Vomiting,6,16989698
4,22.1,Toxicity to various agents,6,16989698
5,22.1,Hypokalaemia,6,16989698
0,22.1,Small cell lung cancer metastatic,6,16989699
1,22.1,Malignant neoplasm progression,6,16989699
0,22.1,Syringe issue,,16989717
1,22.1,Device leakage,,16989717
2,22.1,Intercepted product administration error,,16989717
3,22.1,Wrong technique in product usage process,,16989717
0,22.1,Pneumonia,6,16989736
1,22.1,Malignant neoplasm progression,6,16989736
2,22.1,Atrial fibrillation,6,16989736
0,22.1,Pneumothorax,1,16989750
1,22.1,Disseminated intravascular coagulation,5,16989750
2,22.1,Febrile neutropenia,1,16989750
3,22.1,Platelet count decreased,1,16989750
4,22.1,Pneumonia,5,16989750
5,22.1,Sepsis,5,16989750
0,22.1,Squamous cell carcinoma of the tongue,6,16989777
0,22.1,Death,5,16989813
1,22.1,Muscle spasms,6,16989813
2,22.1,Product dose omission,6,16989813
0,22.1,Hospitalisation,6,16989814
1,22.1,Death,5,16989814
0,22.1,Acidosis,6,16989838
1,22.1,Abdominal pain,5,16989838
0,22.1,Blood creatine phosphokinase increased,3,16989841
0,22.1,Death,5,16989877
0,22.1,Malignant neoplasm progression,6,16989879
0,22.1,Wound,2,16989975
1,22.1,Gastrointestinal tube removal,6,16989975
0,22.1,Metastases to central nervous system,3,16989977
1,22.1,Colon cancer,3,16989977
0,22.1,Diarrhoea,2,16989978
1,22.1,Lymphangiosis carcinomatosa,5,16989978
2,22.1,Hypertension,1,16989978
3,22.1,Pleural effusion,5,16989978
4,22.1,Back pain,6,16989978
5,22.1,Palmar-plantar erythrodysaesthesia syndrome,2,16989978
6,22.1,Malaise,2,16989978
7,22.1,Malignant neoplasm progression,5,16989978
0,22.1,Urinary tract infection,6,16989987
1,22.1,Neuropathy peripheral,6,16989987
2,22.1,Fatigue,6,16989987
3,22.1,Asthenia,6,16989987
0,22.1,Blood creatinine increased,2,16989994
1,22.1,Product use in unapproved indication,6,16989994
0,22.1,Weight decreased,6,16990005
1,22.1,Fatigue,6,16990005
2,22.1,Hypoaesthesia,6,16990005
3,22.1,Gait inability,6,16990005
4,22.1,Muscular weakness,6,16990005
5,22.1,Neuropathy peripheral,6,16990005
6,22.1,Asthenia,6,16990005
7,22.1,Neutropenic sepsis,6,16990005
8,22.1,Diarrhoea,6,16990005
0,22.1,Metastases to bone,6,16990024
1,22.1,Breast cancer metastatic,6,16990024
2,22.1,Metastases to central nervous system,6,16990024
3,22.1,Metastases to pleura,6,16990024
0,22.1,Malignant neoplasm progression,5,16990058
0,22.1,Pyelonephritis,1,16990076
1,22.1,Thrombocytopenia,1,16990076
2,22.1,Anaemia,1,16990076
3,22.1,Neutropenia,1,16990076
4,22.1,Rectal haemorrhage,1,16990076
5,22.1,Neutropenic sepsis,1,16990076
0,22.1,Hospice care,,16990113
0,22.1,Surgery,,16990121
0,22.1,No adverse event,6,16990133
0,22.1,Nausea,1,16990137
1,22.1,Pulmonary embolism,1,16990137
2,22.1,Vomiting,1,16990137
3,22.1,Injection site haemorrhage,1,16990137
4,22.1,Abdominal pain,3,16990137
5,22.1,Decreased appetite,3,16990137
0,22.1,Neuropathy peripheral,6,16990157
1,22.1,Cardiac disorder,6,16990157
2,22.1,Memory impairment,6,16990157
0,22.1,Back pain,1,16990177
0,22.1,Meniscus injury,6,16990200
0,22.1,Death,5,16990236
0,22.1,Hyperkalaemia,1,16990238
0,22.1,Product storage error,6,16990274
0,22.1,Drug ineffective,,16990287
1,22.1,Malaise,,16990287
2,22.1,Vomiting,,16990287
0,22.1,Fatigue,3,16990301
1,22.1,Diarrhoea,3,16990301
2,22.1,Myalgia,3,16990301
3,22.1,Tooth disorder,3,16990301
4,22.1,Hypersomnia,3,16990301
5,22.1,Dehydration,6,16990301
0,22.1,Neutrophil count increased,6,16990352
1,22.1,Multiple organ dysfunction syndrome,5,16990352
2,22.1,Urosepsis,5,16990352
3,22.1,Thrombocytosis,6,16990352
0,22.1,Malignant neoplasm progression,6,16990355
1,22.1,Metastases to central nervous system,2,16990355
2,22.1,Hyperpyrexia,5,16990355
0,22.1,Incorrect route of product administration,,16990357
1,22.1,Vulval abscess,,16990357
2,22.1,Vulvovaginal discomfort,,16990357
3,22.1,Vulvovaginal pain,,16990357
4,22.1,Off label use,,16990357
5,22.1,Bacterial vaginosis,,16990357
6,22.1,Vulvovaginal swelling,,16990357
7,22.1,Vulvovaginal dryness,,16990357
8,22.1,Infection,,16990357
0,22.1,Onychoclasis,6,16990359
1,22.1,Ageusia,6,16990359
2,22.1,Dyspnoea,6,16990359
3,22.1,Skin exfoliation,6,16990359
4,22.1,Decreased appetite,6,16990359
5,22.1,Weight decreased,6,16990359
6,22.1,Thrombosis,6,16990359
0,22.1,Pain in extremity,6,16990388
1,22.1,Fatigue,6,16990388
2,22.1,Joint swelling,6,16990388
0,22.1,Palmar-plantar erythrodysaesthesia syndrome,6,16990390
0,22.1,Back pain,6,16990393
1,22.1,Compression fracture,6,16990393
2,22.1,Hot flush,6,16990393
3,22.1,Fatigue,6,16990393
0,22.1,Vomiting,6,16990394
1,22.1,Abdominal pain,2,16990394
2,22.1,Renal impairment,2,16990394
3,22.1,Hyponatraemia,6,16990394
4,22.1,Hepatic function abnormal,2,16990394
5,22.1,Dyspnoea exertional,6,16990394
6,22.1,Death,5,16990394
7,22.1,Nausea,6,16990394
0,22.1,Gingival disorder,3,16990555
1,22.1,Tooth disorder,3,16990555
2,22.1,Osteonecrosis of jaw,3,16990555
0,22.1,Bone marrow failure,1,16990569
0,22.1,Sudden death,5,16990570
1,22.1,Pneumothorax,6,16990570
2,22.1,Interstitial lung disease,2,16990570
0,22.1,Bronchitis,6,16990593
0,22.1,Sepsis,5,16990609
1,22.1,Pancytopenia,6,16990609
0,22.1,Abdominal pain upper,1,16990615
1,22.1,Carbohydrate antigen 125 increased,1,16990615
2,22.1,Blood pressure increased,1,16990615
3,22.1,Recurrent cancer,6,16990615
4,22.1,Feeling abnormal,6,16990615
5,22.1,Product dose omission,6,16990615
6,22.1,Neoplasm malignant,6,16990615
7,22.1,Vomiting,1,16990615
8,22.1,Small intestinal obstruction,6,16990615
9,22.1,Cognitive disorder,6,16990615
10,22.1,Headache,3,16990615
11,22.1,Dizziness,3,16990615
12,22.1,Underdose,6,16990615
13,22.1,Heart rate increased,3,16990615
14,22.1,Inflammation,6,16990615
15,22.1,Faeces discoloured,6,16990615
0,22.1,Death,5,16990618
0,22.1,Malignant neoplasm progression,5,16990666
1,22.1,Inappropriate schedule of product administration,6,16990666
0,22.1,Anaemia,3,16990682
1,22.1,Haemolysis,3,16990682
2,22.1,Thrombocytopenia,3,16990682
3,22.1,Neutropenia,3,16990682
0,22.1,Confusional state,6,16990685
1,22.1,Dyspnoea,6,16990685
2,22.1,Atrial fibrillation,6,16990685
3,22.1,Lower respiratory tract infection,2,16990685
4,22.1,Neoplasm progression,6,16990685
0,22.1,Hypoxia,1,16990703
1,22.1,Hypersensitivity,1,16990703
2,22.1,Hyperhidrosis,1,16990703
0,22.1,Diarrhoea,1,16990710
1,22.1,Agranulocytosis,1,16990710
2,22.1,Pyrexia,1,16990710
3,22.1,Abdominal pain,1,16990710
4,22.1,Chills,1,16990710
5,22.1,Folliculitis,1,16990710
0,22.1,Acute myeloid leukaemia,3,16990738
1,22.1,Second primary malignancy,3,16990738
2,22.1,Pancytopenia,6,16990738
0,22.1,Off label use,6,16990751
0,22.1,Nausea,1,16990813
1,22.1,Influenza like illness,6,16990813
2,22.1,Vertigo,1,16990813
0,22.1,Alopecia,3,16990815
1,22.1,Psychological trauma,6,16990815
0,22.1,Myalgia,3,16990850
1,22.1,Trigger finger,3,16990850
2,22.1,Arthralgia,3,16990850
0,22.1,Neutrophil count decreased,6,16990859
0,22.1,Drug ineffective,,16990861
1,22.1,Hospitalisation,,16990861
0,22.1,Anxiety,6,16990876
1,22.1,Emotional distress,6,16990876
2,22.1,Impaired quality of life,6,16990876
3,22.1,Pain,6,16990876
4,22.1,Alopecia,2,16990876
5,22.1,Psychological trauma,6,16990876
0,22.1,Psychological trauma,6,16990877
1,22.1,Alopecia,1,16990877
0,22.1,Alopecia,2,16990888
1,22.1,Psychological trauma,6,16990888
0,22.1,Alopecia,2,16990900
1,22.1,Emotional distress,6,16990900
2,22.1,Pain,6,16990900
3,22.1,Anxiety,6,16990900
4,22.1,Impaired quality of life,6,16990900
5,22.1,Psychological trauma,6,16990900
0,22.1,Diabetes mellitus,5,16990914
1,22.1,Organising pneumonia,2,16990914
2,22.1,Arthralgia,1,16990914
3,22.1,Myocardial infarction,5,16990914
0,22.1,Malignant neoplasm progression,5,16990926
0,22.1,Feeding disorder,6,16991005
0,22.1,Suicide attempt,6,16991008
1,22.1,Intentional overdose,6,16991008
0,22.1,Anaemia,6,16991016
1,22.1,Ascites,6,16991016
2,22.1,Drug intolerance,6,16991016
0,22.1,Decreased appetite,6,16991080
1,22.1,Rash,6,16991080
2,22.1,Nausea,6,16991080
3,22.1,Neutrophil count decreased,6,16991080
0,22.1,Decreased appetite,6,16991083
1,22.1,Rash,6,16991083
2,22.1,Stomatitis,6,16991083
3,22.1,Nausea,6,16991083
4,22.1,Neutrophil count decreased,6,16991083
0,22.1,Brain stem haemorrhage,4,16991088
0,22.1,Off label use,6,16991089
1,22.1,Renal impairment,6,16991089
0,22.1,Disseminated intravascular coagulation,6,16991099
1,22.1,Platelet count decreased,6,16991099
2,22.1,Interstitial lung disease,5,16991099
3,22.1,Pneumomediastinum,6,16991099
4,22.1,Anaemia,6,16991099
5,22.1,Haematoma muscle,6,16991099
6,22.1,Sepsis,6,16991099
0,22.1,Death,5,16991199
0,22.1,Bone marrow failure,1,16991226
1,22.1,Total bile acids increased,2,16991226
2,22.1,Blood bilirubin increased,2,16991226
3,22.1,Bilirubin conjugated increased,2,16991226
4,22.1,White blood cell count decreased,1,16991226
5,22.1,Liver injury,2,16991226
0,22.1,Diarrhoea,1,16991228
0,22.1,Renal disorder,3,16991336
0,22.1,Neutropenia,1,16991362
1,22.1,Neutropenia,3,16991362
0,22.1,Intercepted product preparation error,,16991447
1,22.1,Wrong technique in product usage process,,16991447
2,22.1,Syringe issue,,16991447
0,22.1,Cardiac dysfunction,3,16991472
1,22.1,Dyspnoea,2,16991472
2,22.1,Cardiac failure,2,16991472
0,22.1,Hyperglycaemic hyperosmolar nonketotic syndrome,1,16991489
0,22.1,Pyrexia,1,16991520
1,22.1,Eczema,1,16991520
2,22.1,Erythema,1,16991520
0,22.1,Pulmonary embolism,5,16991536
1,22.1,Cardiac arrest,5,16991536
2,22.1,Fatigue,3,16991536
3,22.1,Nasal ulcer,3,16991536
4,22.1,Ageusia,3,16991536
5,22.1,Nausea,3,16991536
6,22.1,Diarrhoea,3,16991536
7,22.1,Decreased appetite,3,16991536
0,22.1,Sepsis,6,16991538
0,22.1,Off label use,6,16991539
1,22.1,Malignant neoplasm progression,5,16991539
0,22.1,Bone marrow failure,6,16991549
0,22.1,Jaundice,1,16991639
0,22.1,Acute myocardial infarction,1,16991645
0,22.1,Diarrhoea,1,16991654
1,22.1,Acute kidney injury,1,16991654
0,22.1,Non-small cell lung cancer recurrent,6,16991754
1,22.1,Product use issue,6,16991754
0,22.1,Colitis,1,16991820
1,22.1,Intestinal perforation,1,16991820
0,22.1,Condition aggravated,5,16991883
1,22.1,Dyspnoea,5,16991883
2,22.1,Respiratory gas exchange disorder,5,16991883
3,22.1,Multiple organ dysfunction syndrome,5,16991883
4,22.1,Immune-mediated pneumonitis,5,16991883
5,22.1,Acute respiratory distress syndrome,5,16991883
6,22.1,Hypoxia,5,16991883
0,22.1,Visual impairment,6,16991995
1,22.1,Myalgia,6,16991995
0,22.1,Fatigue,6,16992109
1,22.1,Dyspnoea,6,16992109
2,22.1,Alanine aminotransferase increased,6,16992109
3,22.1,Neurological symptom,1,16992109
4,22.1,Autoimmune myocarditis,4,16992109
5,22.1,Autoimmune hepatitis,1,16992109
0,22.1,Death,5,16992248
0,22.1,Inappropriate schedule of product administration,6,16992336
1,22.1,Product use in unapproved indication,6,16992336
0,22.1,Surgery,,16992416
0,22.1,Hospitalisation,,16992424
0,22.1,Palmar-plantar erythrodysaesthesia syndrome,,16992430
1,22.1,Pneumonia,,16992430
0,22.1,Malignant neoplasm progression,2,16992477
1,22.1,Haemoglobin decreased,2,16992477
2,22.1,Prostatic specific antigen increased,2,16992477
3,22.1,Fatigue,2,16992477
0,22.1,Death,,16992526
0,22.1,Metastases to lung,3,16992551
1,22.1,Femoral neck fracture,3,16992551
0,22.1,Encephalopathy,6,16992603
0,22.1,Pulmonary oedema,6,16992618
0,22.1,Cardiac failure acute,1,16992664
0,22.1,Cardiac failure,5,16992715
0,22.1,Pulmonary oedema,2,16992724
0,22.1,Death,5,16992751
0,22.1,Paranasal sinus hypersecretion,6,16992757
1,22.1,Cough,6,16992757
2,22.1,Rash,1,16992757
0,22.1,Productive cough,3,16992826
1,22.1,Hair colour changes,1,16992826
2,22.1,Dyspnoea,3,16992826
3,22.1,Dry mouth,1,16992826
4,22.1,Hypothyroidism,3,16992826
5,22.1,Hypoxia,3,16992826
6,22.1,Hypertrichosis,1,16992826
7,22.1,Oesophagitis,1,16992826
8,22.1,Wheezing,3,16992826
9,22.1,Haemoptysis,3,16992826
10,22.1,Musculoskeletal chest pain,1,16992826
11,22.1,Gamma-glutamyltransferase increased,3,16992826
12,22.1,Basal cell carcinoma,1,16992826
13,22.1,Hyperglycaemia,2,16992826
0,22.1,Prostate cancer,5,16992840
0,22.1,Arthropathy,,16992843
1,22.1,Therapy cessation,,16992843
0,22.1,Vision blurred,1,16992844
1,22.1,Hyperhidrosis,1,16992844
2,22.1,Dyspnoea,1,16992844
3,22.1,Paraesthesia,1,16992844
4,22.1,Muscle spasms,1,16992844
0,22.1,Oral discomfort,,16992849
1,22.1,Hypoaesthesia oral,,16992849
2,22.1,Gingival bleeding,,16992849
0,22.1,Hospitalisation,,16992852
0,22.1,Malaise,3,16992868
0,22.1,Prinzmetal angina,1,16992888
0,22.1,Bronchitis,,16992910
1,22.1,Wheezing,,16992910
2,22.1,Sinusitis,,16992910
0,22.1,Full blood count decreased,,16992911
0,22.1,Adverse reaction,6,16992927
0,22.1,Liver disorder,3,16992935
1,22.1,Neoplasm progression,3,16992935
0,22.1,Constipation,6,16992987
1,22.1,Fatigue,6,16992987
2,22.1,Malaise,6,16992987
3,22.1,Feeling jittery,6,16992987
4,22.1,Pyrexia,6,16992987
5,22.1,Neutropenia,6,16992987
6,22.1,Pneumonia,6,16992987
7,22.1,Anaemia,6,16992987
8,22.1,Muscular weakness,6,16992987
9,22.1,Dehydration,6,16992987
10,22.1,Asthenia,6,16992987
11,22.1,Disturbance in attention,6,16992987
12,22.1,Hyperkalaemia,6,16992987
0,22.1,Herpes zoster,6,16993111
0,22.1,Death,5,16993119
0,22.1,Hypertension,4,16993122
0,22.1,Febrile neutropenia,1,16993133
0,22.1,Pain,6,16993172
1,22.1,Oedema peripheral,2,16993172
2,22.1,Underdose,6,16993172
3,22.1,Fall,6,16993172
4,22.1,Muscular weakness,6,16993172
5,22.1,Pulmonary oedema,3,16993172
0,22.1,Hypertension,1,16993179
1,22.1,Diverticulitis,6,16993179
2,22.1,Pain,2,16993179
3,22.1,Tendonitis,6,16993179
4,22.1,Abdominal discomfort,1,16993179
5,22.1,Diarrhoea,6,16993179
6,22.1,Decreased appetite,2,16993179
7,22.1,Nausea,3,16993179
8,22.1,Asthenia,6,16993179
9,22.1,Depression,3,16993179
10,22.1,Fatigue,6,16993179
11,22.1,Nail growth abnormal,6,16993179
12,22.1,Constipation,3,16993179
13,22.1,Product dose omission,6,16993179
0,22.1,Hypophosphataemia,1,16993193
1,22.1,Hypomagnesaemia,1,16993193
2,22.1,Hypocalcaemia,1,16993193
3,22.1,Hypokalaemia,1,16993193
0,22.1,Death,,16993199
0,22.1,Blood glucose increased,,16993218
0,22.1,Disease progression,,16993220
0,22.1,Death,5,16993232
0,22.1,Erythema,1,16993341
1,22.1,Hypotension,1,16993341
2,22.1,Dizziness,1,16993341
3,22.1,Oxygen saturation decreased,1,16993341
4,22.1,Pruritus,1,16993341
5,22.1,Anaphylactic reaction,1,16993341
0,22.1,Oropharyngeal pain,3,16993353
1,22.1,Fatigue,3,16993353
2,22.1,Malaise,3,16993353
3,22.1,Skin indentation,3,16993353
4,22.1,Vomiting,3,16993353
5,22.1,Dyspnoea,3,16993353
6,22.1,Dysphagia,3,16993353
7,22.1,Haematemesis,6,16993353
8,22.1,Pneumonia,3,16993353
9,22.1,Diarrhoea,1,16993353
10,22.1,Constipation,2,16993353
11,22.1,Blood glucose decreased,3,16993353
12,22.1,Non-cardiac chest pain,3,16993353
13,22.1,Peripheral swelling,3,16993353
14,22.1,Nasopharyngitis,3,16993353
15,22.1,Laryngitis,6,16993353
16,22.1,Dizziness,3,16993353
17,22.1,Joint swelling,3,16993353
18,22.1,Nausea,3,16993353
19,22.1,Insomnia,3,16993353
20,22.1,Swelling,3,16993353
21,22.1,Muscle spasms,3,16993353
22,22.1,Asthenia,3,16993353
23,22.1,Anger,2,16993353
24,22.1,Hypertension,3,16993353
25,22.1,Arthralgia,3,16993353
26,22.1,Rash pruritic,3,16993353
27,22.1,Cardiac flutter,3,16993353
28,22.1,Pain in extremity,3,16993353
0,22.1,Hospice care,,16993359
0,22.1,Thrombocytopenia,3,16993388
1,22.1,Neutropenia,2,16993388
2,22.1,Leukopenia,3,16993388
3,22.1,Chills,1,16993388
4,22.1,Anaemia,1,16993388
5,22.1,Cystitis,1,16993388
6,22.1,Eastern Cooperative Oncology Group performance status worsened,3,16993388
7,22.1,Pyrexia,1,16993388
8,22.1,Death,5,16993388
9,22.1,Hypotension,1,16993388
10,22.1,Decreased appetite,6,16993388
0,22.1,Off label use,6,16993391
1,22.1,Bundle branch block left,6,16993391
2,22.1,Atrial fibrillation,6,16993391
0,22.1,Acute kidney injury,1,16993408
1,22.1,Dehydration,1,16993408
2,22.1,Vomiting,1,16993408
3,22.1,Somnolence,1,16993408
4,22.1,Urinary retention,1,16993408
0,22.1,Acute kidney injury,1,16993416
1,22.1,Diarrhoea,1,16993416
2,22.1,Dehydration,1,16993416
0,22.1,Hypothalamo-pituitary disorder,1,16993418
1,22.1,Interstitial lung disease,1,16993418
0,22.1,Death,5,16993419
0,22.1,Bone disorder,4,16993444
1,22.1,Eyelid ptosis,3,16993444
2,22.1,Dyspepsia,3,16993444
0,22.1,Posterior reversible encephalopathy syndrome,1,16993483
0,22.1,Acute lymphocytic leukaemia,3,16993547
1,22.1,Pancytopenia,6,16993547
2,22.1,Weight decreased,6,16993547
3,22.1,Herpes simplex test positive,6,16993547
4,22.1,Myalgia,6,16993547
5,22.1,Second primary malignancy,3,16993547
6,22.1,Neutrophil count decreased,3,16993547
7,22.1,Epstein-Barr virus antibody positive,6,16993547
8,22.1,Abdominal pain upper,6,16993547
9,22.1,Decreased appetite,6,16993547
10,22.1,Cytomegalovirus test positive,6,16993547
11,22.1,Concomitant disease aggravated,6,16993547
12,22.1,Febrile neutropenia,6,16993547
13,22.1,Asthenia,6,16993547
0,22.1,Anaemia,1,16993594
1,22.1,Neutropenia,1,16993594
2,22.1,Nasopharyngitis,1,16993594
0,22.1,Persistent depressive disorder,2,16993643
1,22.1,Fatigue,2,16993643
2,22.1,Off label use,6,16993643
3,22.1,Pruritus,2,16993643
0,22.1,Cardio-respiratory arrest,5,16993649
0,22.1,Ileus,1,16993655
0,22.1,Abdominal pain upper,3,16993687
1,22.1,Fluid retention,3,16993687
2,22.1,Carbohydrate antigen 125 increased,6,16993687
3,22.1,Gastrointestinal scarring,6,16993687
4,22.1,Incontinence,6,16993687
5,22.1,Back pain,6,16993687
6,22.1,Intra-abdominal fluid collection,6,16993687
7,22.1,Dyspepsia,6,16993687
8,22.1,Discoloured vomit,6,16993687
9,22.1,Decreased appetite,3,16993687
10,22.1,Nausea,3,16993687
11,22.1,Constipation,6,16993687
12,22.1,Underdose,6,16993687
13,22.1,Solar lentigo,6,16993687
14,22.1,Product dose omission,6,16993687
15,22.1,Depression,6,16993687
16,22.1,Weight decreased,3,16993687
17,22.1,White blood cell count decreased,6,16993687
18,22.1,Intestinal obstruction,3,16993687
19,22.1,Fluid replacement,6,16993687
20,22.1,Eating disorder,6,16993687
21,22.1,Vomiting,3,16993687
22,22.1,Blood count abnormal,6,16993687
23,22.1,Fatigue,6,16993687
0,22.1,Hyperkalaemia,3,16993694
1,22.1,Myositis,5,16993694
2,22.1,Platelet count decreased,3,16993694
3,22.1,Pneumonia aspiration,5,16993694
0,22.1,Arthritis,6,16993696
1,22.1,Interstitial lung disease,6,16993696
2,22.1,Rash,6,16993696
0,22.1,Pain in extremity,3,16993710
1,22.1,Pain,3,16993710
2,22.1,Decreased appetite,3,16993710
3,22.1,Myalgia,3,16993710
4,22.1,Bone pain,3,16993710
5,22.1,Nausea,1,16993710
6,22.1,Hypertension,1,16993710
7,22.1,Back pain,6,16993710
8,22.1,Weight decreased,6,16993710
9,22.1,Condition aggravated,3,16993710
10,22.1,Constipation,3,16993710
11,22.1,Arthralgia,3,16993710
12,22.1,Diarrhoea,1,16993710
13,22.1,Intentional dose omission,6,16993710
14,22.1,Fatigue,3,16993710
0,22.1,Atrial fibrillation,3,16993718
1,22.1,Decreased appetite,1,16993718
2,22.1,Peripheral coldness,1,16993718
3,22.1,Regurgitation,6,16993718
4,22.1,Dyspnoea,3,16993718
5,22.1,Lacrimation increased,6,16993718
6,22.1,Off label use,6,16993718
7,22.1,Vasodilatation,1,16993718
8,22.1,Weight decreased,1,16993718
9,22.1,Vomiting,1,16993718
10,22.1,Platelet count decreased,6,16993718
11,22.1,Fatigue,2,16993718
12,22.1,Palmar erythema,1,16993718
0,22.1,Intentional dose omission,6,16993723
1,22.1,Hair growth abnormal,6,16993723
2,22.1,Blood pressure increased,2,16993723
3,22.1,Renal impairment,6,16993723
4,22.1,Fatigue,6,16993723
5,22.1,Sinusitis,3,16993723
6,22.1,Insomnia,6,16993723
0,22.1,Peripheral swelling,6,16993727
1,22.1,Product dose omission,6,16993727
2,22.1,Platelet count decreased,6,16993727
3,22.1,Abdominal discomfort,6,16993727
4,22.1,Fatigue,6,16993727
0,22.1,Diarrhoea,6,16993728
1,22.1,Headache,3,16993728
2,22.1,Nausea,3,16993728
3,22.1,Intestinal obstruction,6,16993728
4,22.1,Chills,6,16993728
0,22.1,Upper limb fracture,6,16993749
0,22.1,Death,5,16993774
0,22.1,Neutropenia,6,16993775
1,22.1,Blood cholesterol increased,6,16993775
2,22.1,Blood triglycerides increased,6,16993775
0,22.1,Haematotoxicity,6,16993788
1,22.1,Dyslipidaemia,6,16993788
0,22.1,Death,5,16993854
1,22.1,Neoplasm progression,6,16993854
0,22.1,Pupillary reflex impaired,6,16993927
1,22.1,Respiratory failure,6,16993927
2,22.1,Tachycardia,6,16993927
3,22.1,Circulatory collapse,6,16993927
4,22.1,Nausea,6,16993927
5,22.1,Acidosis,6,16993927
6,22.1,Erythema,6,16993927
7,22.1,Flushing,2,16993927
8,22.1,Vomiting,6,16993927
9,22.1,Blood pressure decreased,6,16993927
10,22.1,Respiratory arrest,6,16993927
11,22.1,Loss of consciousness,2,16993927
12,22.1,Heart rate decreased,6,16993927
13,22.1,Pulse absent,6,16993927
14,22.1,Anaphylactic shock,5,16993927
15,22.1,Pallor,2,16993927
0,22.1,Detachment of retinal pigment epithelium,1,16993945
0,22.1,Malignant neoplasm progression,5,16993949
1,22.1,Back pain,3,16993949
2,22.1,Ascites,3,16993949
3,22.1,Asthenia,1,16993949
4,22.1,Abdominal pain,6,16993949
5,22.1,Ascites,1,16993949
6,22.1,Diarrhoea,3,16993949
7,22.1,Cough,1,16993949
8,22.1,Renal cancer metastatic,5,16993949
9,22.1,Dyspepsia,3,16993949
10,22.1,Oedema peripheral,3,16993949
0,22.1,Cardiac arrest,5,16993973
1,22.1,Loss of consciousness,6,16993973
0,22.1,Platelet count decreased,2,16993987
1,22.1,Anaemia,2,16993987
2,22.1,Bone marrow failure,6,16993987
3,22.1,Neutrophil count decreased,2,16993987
0,22.1,Cerebrovascular accident,3,16993991
0,22.1,Prostate cancer,,16994019
1,22.1,Haemoglobin decreased,,16994019
0,22.1,Cough,6,16994055
1,22.1,Nausea,6,16994055
2,22.1,Vomiting,6,16994055
3,22.1,Arthralgia,6,16994055
4,22.1,Fatigue,6,16994055
5,22.1,Pulmonary oedema,6,16994055
0,22.1,Cardiac arrest,3,16994058
0,22.1,Dyspnoea,6,16994062
1,22.1,Generalised oedema,6,16994062
2,22.1,Weight increased,6,16994062
3,22.1,Capillary leak syndrome,6,16994062
0,22.1,Hepatitis cholestatic,1,16994072
0,22.1,Malignant neoplasm progression,3,16994205
1,22.1,Pericardial effusion,1,16994205
2,22.1,Cardiac tamponade,6,16994205
3,22.1,Non-small cell lung cancer stage IV,3,16994205
4,22.1,Liver disorder,1,16994205
0,22.1,Prostate cancer,,16994208
1,22.1,Lymphocyte count decreased,,16994208
0,22.1,Stoma complication,2,16994230
1,22.1,Rectal cancer,5,16994230
2,22.1,Disease progression,5,16994230
3,22.1,Stoma site ulcer,2,16994230
0,22.1,Pneumonia,6,16994297
1,22.1,Renal disorder,6,16994297
2,22.1,Pneumonitis,6,16994297
3,22.1,Pulmonary mass,6,16994297
4,22.1,Bone disorder,6,16994297
0,22.1,Adenomyosis,6,16994300
1,22.1,Pneumonitis,6,16994300
2,22.1,Gallbladder enlargement,6,16994300
3,22.1,Pleural thickening,6,16994300
0,22.1,Death,5,16994309
1,22.1,Inappropriate schedule of product administration,6,16994309
0,22.1,Arthralgia,2,16994311
0,22.1,Malignant neoplasm progression,6,16994325
1,22.1,Hepatic function abnormal,3,16994325
2,22.1,Parotitis,2,16994325
3,22.1,Diarrhoea,1,16994325
0,22.1,Feeding disorder,6,16994326
0,22.1,Neutropenia,3,16994336
1,22.1,Diarrhoea,3,16994336
0,22.1,Hepatitis fulminant,1,16994368
0,22.1,Muscle spasms,2,16994370
1,22.1,Fatigue,3,16994370
2,22.1,Myalgia,3,16994370
3,22.1,Prescribed underdose,6,16994370
4,22.1,Hepatic function abnormal,1,16994370
5,22.1,Malaise,3,16994370
6,22.1,Abdominal discomfort,2,16994370
7,22.1,Blood glucose increased,6,16994370
8,22.1,Breast pain,6,16994370
9,22.1,Blood pressure increased,2,16994370
10,22.1,Hypokalaemia,2,16994370
11,22.1,Hepatic function abnormal,1,16994370
12,22.1,Trigger finger,1,16994370
13,22.1,Injection site induration,2,16994370
14,22.1,Insomnia,2,16994370
15,22.1,Pyrexia,2,16994370
0,22.1,Anaemia,6,16994395
1,22.1,Synovial cyst,6,16994395
2,22.1,Carbohydrate antigen 125 increased,6,16994395
3,22.1,Abdominal discomfort,6,16994395
4,22.1,Asthenia,6,16994395
5,22.1,Hypertension,6,16994395
6,22.1,Ovarian cancer,6,16994395
7,22.1,Ascites,6,16994395
8,22.1,Peritoneal disorder,6,16994395
0,22.1,Breast cancer metastatic,6,16994405
1,22.1,Metastases to liver,6,16994405
2,22.1,Malignant neoplasm progression,6,16994405
3,22.1,Therapy non-responder,6,16994405
4,22.1,Pleural effusion,6,16994405
5,22.1,Polyneuropathy,6,16994405
6,22.1,Dyspnoea,6,16994405
0,22.1,Malignant neoplasm progression,6,16994407
0,22.1,Infectious pleural effusion,1,16994433
0,22.1,Loss of consciousness,6,16994522
1,22.1,Fall,6,16994522
0,22.1,Pyrexia,6,16994553
1,22.1,Fatigue,6,16994553
2,22.1,Death,5,16994553
3,22.1,Limb discomfort,6,16994553
4,22.1,Arthralgia,6,16994553
5,22.1,Asthenia,6,16994553
6,22.1,Underdose,6,16994553
7,22.1,Swelling,6,16994553
8,22.1,Cystitis,6,16994553
0,22.1,Prostate cancer,,16994595
1,22.1,Haemoglobin decreased,,16994595
0,22.1,Prostate cancer,,16994596
1,22.1,Lymphocyte count decreased,,16994596
0,22.1,Prostate cancer,,16994598
1,22.1,Haemoglobin decreased,,16994598
0,22.1,Fatigue,2,16994602
1,22.1,Bone pain,6,16994602
2,22.1,Gait inability,1,16994602
3,22.1,Malignant neoplasm progression,6,16994602
4,22.1,Prostatic specific antigen increased,3,16994602
0,22.1,Neoplasm malignant,3,16994617
1,22.1,Pruritus,3,16994617
2,22.1,Prostatic specific antigen increased,6,16994617
3,22.1,Diarrhoea,3,16994617
4,22.1,Abdominal discomfort,3,16994617
0,22.1,Hypophysitis,6,16994630
0,22.1,Fatigue,6,16994643
1,22.1,Haemolytic anaemia,6,16994643
2,22.1,Malaise,6,16994643
3,22.1,Pyrexia,6,16994643
0,22.1,Dyspnoea,,16994649
1,22.1,Pain,,16994649
0,22.1,Metastases to bone,6,16994663
1,22.1,Prostate cancer,6,16994663
0,22.1,Leukaemia,6,16994670
0,22.1,Blood creatinine increased,1,16994689
1,22.1,Back pain,2,16994689
2,22.1,Neoplasm progression,6,16994689
3,22.1,Purulent discharge,4,16994689
4,22.1,Transaminases increased,1,16994689
5,22.1,Otitis media,6,16994689
6,22.1,Scar,6,16994689
0,22.1,Palmar-plantar erythrodysaesthesia syndrome,2,16994744
1,22.1,Mucosal inflammation,2,16994744
2,22.1,Neuropathy peripheral,3,16994744
0,22.1,Psoriasis,2,16994778
1,22.1,Immune-mediated adverse reaction,6,16994778
2,22.1,Toxicity to various agents,6,16994778
0,22.1,Interstitial lung disease,2,16994900
1,22.1,Portal vein thrombosis,6,16994900
